Literature DB >> 22783391

Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus.

Yutaka Tomizawa1, Tsung-Teh Wu, Kenneth K Wang.   

Abstract

Carcinomas comprise cohesive epithelial cells linked to one another by E-cadherin-based cell-cell junctions. Epithelial mesenchymal transition (EMT) enables carcinoma cells to migrate from the original tissue and invade into stromal components. The E-cadherin promoter is frequently repressed by specific transcriptional repressors including Snail, Slug and Twist. CD133 is known to be a marker of tumor-initiating cells in human cancers. This is the first study to characterize the transcriptional factors for E-cadherin and the representative cancer stem cell marker in specimens of early esophageal adenocarcinoma (EAC) originating from Barrett's esophagus. Ten surgically treated patients were analyzed in the present study. Immunohistochemistry was performed to determine the expression of Snail, Slug, Twist and CD133, and the results were scored. Unlike previous studies of advanced stage esophageal cancers showing the overexpression of each specific transcriptional protein, the invading edges of the tumor were found to abundantly express Snail, Slug, Twist and CD133 in our cohort. Therefore, results of this study suggest that early stage cancers predominantly comprise cells with metastatic potential and this evidence adds legitimacy to the complete removal of early EAC.

Entities:  

Year:  2012        PMID: 22783391      PMCID: PMC3389641          DOI: 10.3892/ol.2012.632

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 2.  Tumor metastasis: a new twist on epithelial-mesenchymal transitions.

Authors:  Ann E Vernon; Carole LaBonne
Journal:  Curr Biol       Date:  2004-09-07       Impact factor: 10.834

3.  Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.

Authors:  Shoji Natsugoe; Yasuto Uchikado; Hiroshi Okumura; Masataka Matsumoto; Tetsuro Setoyama; Kiyokazu Tamotsu; Yoshiaki Kita; Akihiko Sakamoto; Testuhiro Owaki; Sumiya Ishigami; Takashi Aikou
Journal:  Oncol Rep       Date:  2007-03       Impact factor: 3.906

4.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

Review 5.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

6.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Authors:  Simone Spaderna; Otto Schmalhofer; Falk Hlubek; Geert Berx; Andreas Eger; Susanne Merkel; Andreas Jung; Thomas Kirchner; Thomas Brabletz
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

Review 7.  Epithelial-mesenchymal transition and tumour invasion.

Authors:  Marcello Guarino
Journal:  Int J Biochem Cell Biol       Date:  2007-07-31       Impact factor: 5.085

8.  Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.

Authors:  Rami J Badreddine; Ganapathy A Prasad; Jason T Lewis; Lori S Lutzke; Lynn S Borkenhagen; Kelly T Dunagan; Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-27       Impact factor: 11.382

Review 9.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

10.  Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Tsung Teh Wu; Dennis A Wigle; Navtej S Buttar; Louis-Michel Wongkeesong; Kelly T Dunagan; Lori S Lutzke; Lynn S Borkenhagen; Kenneth K Wang
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

View more
  13 in total

Review 1.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

2.  Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.

Authors:  Puya Gharahkhani; Rebecca C Fitzgerald; Thomas L Vaughan; Claire Palles; Ines Gockel; Ian Tomlinson; Matthew F Buas; Andrea May; Christian Gerges; Mario Anders; Jessica Becker; Nicole Kreuser; Tania Noder; Marino Venerito; Lothar Veits; Thomas Schmidt; Hendrik Manner; Claudia Schmidt; Timo Hess; Anne C Böhmer; Jakob R Izbicki; Arnulf H Hölscher; Hauke Lang; Dietmar Lorenz; Brigitte Schumacher; Andreas Hackelsberger; Rupert Mayershofer; Oliver Pech; Yogesh Vashist; Katja Ott; Michael Vieth; Josef Weismüller; Markus M Nöthen; Stephen Attwood; Hugh Barr; Laura Chegwidden; John de Caestecker; Rebecca Harrison; Sharon B Love; David MacDonald; Paul Moayyedi; Hans Prenen; R G Peter Watson; Prasad G Iyer; Lesley A Anderson; Leslie Bernstein; Wong-Ho Chow; Laura J Hardie; Jesper Lagergren; Geoffrey Liu; Harvey A Risch; Anna H Wu; Weimin Ye; Nigel C Bird; Nicholas J Shaheen; Marilie D Gammon; Douglas A Corley; Carlos Caldas; Susanne Moebus; Michael Knapp; Wilbert H M Peters; Horst Neuhaus; Thomas Rösch; Christian Ell; Stuart MacGregor; Paul Pharoah; David C Whiteman; Janusz Jankowski; Johannes Schumacher
Journal:  Lancet Oncol       Date:  2016-08-12       Impact factor: 41.316

3.  CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.

Authors:  Joana Cardoso; Marta Mesquita; António Dias Pereira; Mónica Bettencourt-Dias; Paula Chaves; José B Pereira-Leal
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.

Authors:  Runping Liu; Xiaojiaoyang Li; Phillip B Hylemon; Huiping Zhou
Journal:  Am J Pathol       Date:  2018-06-30       Impact factor: 5.770

5.  Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients.

Authors:  Md Raghibul Hasan; Rinu Sharma; Anoop Saraya; Tushar K Chattopadhyay; Siddartha DattaGupta; Paul G Walfish; Shyam S Chauhan; Ranju Ralhan
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

6.  DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Raynoo Thanan; Ning Ma; Yusuke Hiraku; Katsunori Iijima; Tomoyuki Koike; Tooru Shimosegawa; Mariko Murata; Shosuke Kawanishi
Journal:  Mediators Inflamm       Date:  2016-03-10       Impact factor: 4.711

7.  BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.

Authors:  Christine Kestens; Peter D Siersema; G Johan A Offerhaus; Jantine W P M van Baal
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

8.  Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.

Authors:  Chase Taylor; Holli A Loomans; Gregoire F Le Bras; Rainelli B Koumangoye; Alejandra I Romero-Morales; Laura L Quast; Alexander I Zaika; Wael El-Rifai; Thomas Andl; Claudia D Andl
Journal:  Oncotarget       Date:  2015-10-27

9.  Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.

Authors:  Lei Wang; Joy Q Jin; Yong Zhou; Ziqiang Tian; David M Jablons; Biao He
Journal:  Oncotarget       Date:  2017-12-01

10.  CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma.

Authors:  Thomas Artur Werner; Christina Maria Forster; Levent Dizdar; Pablo Emilio Verde; Katharina Raba; Matthias Schott; Wolfram Trudo Knoefel; Andreas Krieg
Journal:  J Cancer       Date:  2018-02-27       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.